MKI67 and serous adenocarcinoma: Ki-67 labeling index (LI) revealed the highest proliferative potential in serous adenocarcinoma, with an average of 20.8% (endometrioid, 15.8%; clear cell, 7.3%; and mucinous, 9.4%).